SAWAI GROUP HOLDINGS Co.,Ltd.

サワイグループホールディングス

Industry: Pharmaceutical
Market: Prime
Accounting standards: IFRS
Consolidation basis: Consolidated

Notes

Stock adjustments
Oct 1, 2024 Stock split 1 share → 3 shares

Key metrics

Revenue(million JPY)

Mar 2022

193,816

Mar 2023

200,344

Mar 2024

176,862

Mar 2025

189,024

Operating profit(million JPY)

Mar 2022

-35,888

Mar 2023

16,984

Mar 2024

18,620

Mar 2025

4,050

Operating profit margin(%)

Mar 2022

-18.52

Mar 2023

8.48

Mar 2024

10.53

Mar 2025

2.14

Profit before tax(million JPY)

Mar 2022

-36,214

Mar 2023

16,789

Mar 2024

18,262

Mar 2025

3,161

Profit(million JPY)

Mar 2022

-28,269

Mar 2023

12,667

Mar 2024

13,695

Mar 2025

11,969

Total assets(million JPY)

Mar 2022

349,502

Mar 2023

364,165

Mar 2024

382,024

Mar 2025

354,623

Cash and cash equivalents(million JPY)

Mar 2022

47,717

Mar 2023

33,076

Mar 2024

26,368

Mar 2025

38,785

Cash flows from operating activities(million JPY)

Mar 2022

34,310

Mar 2023

13,026

Mar 2024

23,149

Mar 2025

27,851

Cash flows from investing activities(million JPY)

Mar 2022

-30,395

Mar 2023

-27,134

Mar 2024

-23,112

Mar 2025

6,480

Cash flows from financing activities(million JPY)

Mar 2022

-11,262

Mar 2023

-1,267

Mar 2024

2,363

Mar 2025

-32,704

Return on equity(%)

Mar 2022

-13.8

Mar 2023

6.5

Mar 2024

6.6

Mar 2025

6.2

Equity ratio(%)

Mar 2022

54.4

Mar 2023

55.4

Mar 2024

55.7

Mar 2025

Earnings per share(JPY per share)

Mar 2022

-215.1767

Mar 2023

96.4167

Mar 2024

104.2233

Mar 2025

96.54

Net assets per share(JPY per share)

Mar 2022

1,446.7733

Mar 2023

1,534.89

Mar 2024

1,618.32

Mar 2025

1,505.86

Dividend per share(JPY per share)

Mar 2022

43.3333

Mar 2023

43.3333

Mar 2024

43.3333

Mar 2025

Payout ratio(%)

Mar 2022

Mar 2023

44.94

Mar 2024

41.58

Mar 2025

54.9

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.